AVONEX(R), the Most Prescribed Multiple Sclerosis Therapy Worldwide, Launched in Japan
CNW Group via Yahoo! Finance Wed, 08 Nov 2006 5:30 AM PST
Biogen Idec announced today that AVONEX , the most prescribed multiple sclerosis therapy worldwide, is now available in Japan. AVONEX is available in more than 90 countries, and its introduction in Japan extends Biogen Idec's leadership in the treatment of MS to an important and underserved market.

AVONEX(R), the Most Prescribed Multiple Sclerosis Therapy Worldwide, Launched in Japan wallstreet:online AG Wed, 08 Nov 2006 5:40 AM PST Biogen Idec (7707;NASDAQ:BIIB) announced today that AVONEX(R) (Interferon beta-1a), the most prescribed

Critical Outcome Technologies Inc. Announces the Final Selection of Its Library of Orally Available Lead Compounds for RedNova Tue, 07 Nov 2006 11:23 AM PST Critical Outcome Technologies Inc. (TSX VENTURE: COT), a computational drug discovery and pre-clinical drug development company, has completed the discovery, optimization and final selection of its library of lead compounds for the oral treatment of acute Multiple Sclerosis.

New stem cell trial for heart attack patients Reuters via Yahoo! News Wed, 08 Nov 2006 2:50 AM PST British doctors said on Wednesday they plan to inject stem cells into heart attack patients in an experimental treatment aimed at preventing heart failure and deaths.

Australia Senate lifts ban on cloning AP via Yahoo! News Tue, 07 Nov 2006 7:31 PM PST Australia's Senate narrowly voted to end the country's four-year ban on cloning human embryos for stem cell research, ruling Tuesday that the potential for medical breakthroughs outweighed moral doubts.

Scientists Use Gene Therapy To Improve Memory And Learning In Animals Science Daily Wed, 08 Nov 2006 10:10 AM PST Stanford University neuroscientists have designed a gene that enhances memory and learning ability in animals under stress. Writing in the November 8 issue of the Journal of Neuroscience, the Stanford team says that the experimental technique might one day lead to new forms of gene therapy that can reduce the severe neurological side effects of steroids, which are prescribed to millions of

Stroke Survivors Benefit Significantly From Targeted Spasticity Treatment Using Medtronic Drug Pump, Study Finds
RedNova Wed, 08 Nov 2006 10:15 AM PST
A new study of stroke survivors shows that treatment delivered with an implantable drug pump from Medtronic, Inc. (NYSE:MDT) significantly improved patients' muscle tone, functional independence and quality of life.

---

FTY720

Lung DCs Legitimate Targets For Treating Asthma
Medical News Today (press release) - UK
... Bart Lambrecht and colleagues from Erasmus University, The Netherlands, have shown that inhalation of the immunosuppressive drug FTY720 suppresses the symptoms ...

---

Tysabri

Biogen says profit up, but cancer drug may go
Bizjournals.com - Charlotte,NC,USA
... Controversial MS treatment Tysabri, which had been pulled from the market over safety concerns, returned to market earlier this year with tougher use guidelines ...

---

Fampridine

Banc of America Starts Acorda Therapeutics (ACOR) at Buy
StreetInsider.com (subscription) - Birmingham,MI,USA
... management of spasticity. Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS.

Acorda Therapeutics (ACOR) Reports Q3 Loss, Comments on Fampridine ...
StreetInsider.com (subscription) - Birmingham,MI,USA
Ron Cohen, MD, President and CEO said "We believe that Fampridine-SR, if approved, could be a first-in-class product, as no existing therapies are indicated to ...